CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent, Antidiabetics, Laxatives, Antifungals, Antihistamines, Antiseptics, Antiulcerants, Cardiovascular drugs, Skeletal, Muscle relaxants, Hypolipaemics, Antineoplastic, Antihyperlipedemia and Immunosuppresant. In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 19 products with the FDA.

In May 2014,CCSB passed again the FDA inspection of their cGMP plant to produce synthesis and biotechnology products.

CCSB has established a sales office, in 1999 Pharmaports LLC in Exton, PA USA to promote its products and provide better services to the North American region. Together, the group has formed an international network providing pharmaceutical ingredients and finished dosages.

CCSB will continuously pursue the goal of quality product, quality service and quality people to become a world-wide major supplier of high quality APIs with competitive prices.

Membership
CCSB, as a member of GPhA, actively participates in international generic industry regulatory issues.